MBX Biosciences to Participate in Upcoming November Investor Conferences
MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $44.00 price target on the stock.
MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $30.00 price target on the stock.
MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $35.00 price target on the stock.
MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $40.00 price target on the stock.